Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Emulating start-up success with purpose-built data tools

Posted on December 12th, 2018 by

Innovation used to be almost solely accredited to Big Pharma, but many of the more established businesses in the industry are finding that their rate of discovery is slowing as they try to find answers to some the industry’s biggest problems, such as antibiotic resistance. Continue reading “Emulating start-up success with purpose-built data tools” »

Games and Events: A New Era of Coopetition in Pharma R&D

Posted on December 8th, 2018 by

Although R&D competition remains as fierce as ever, many pharmaceutical companies engage in various types of cooperation and partnership ventures to help drive innovation. The goal of coopetition — when companies cooperate on certain projects while maintaining a competitive stance — is to make drug development more efficient and effective. Continue reading “Games and Events: A New Era of Coopetition in Pharma R&D” »

Researchers at LegoChem Biosciences Share How Information Solutions Power Their Innovative Work

Posted on December 4th, 2018 by

With its groundbreaking work in developing antibody-drug conjugates, antibiotics, anti-coagulants and anti-cancer therapies, LegoChem Biosciences was already doing important research before joining The Hive. Continue reading “Researchers at LegoChem Biosciences Share How Information Solutions Power Their Innovative Work” »

Small Biotechs Progressing Beyond Startup Status

Posted on November 29th, 2018 by

When is a startup no longer a startup? Small biotech companies armed with a talented crop of scientists have been springing up all across the pharma landscape for the last several years, establishing buzzing hubs of innovation. Not all of them find their research efforts successful, but many do and then go on to be acquired by larger pharmaceutical firms that have the resources to bring their ideas to fruition. Continue reading “Small Biotechs Progressing Beyond Startup Status” »

  1. 1
  2. 2
  3. 3
  4. 62